tiprankstipranks
CombiGene AB (SE:LARK)
:LARK
Sweden Market
LARK
CombiGene AB
RESEARCH TOOLSreports
Want to see SE:LARK full AI Analyst Report?

CombiGene AB (LARK) Financial Statements

0 Followers

CombiGene AB Financial Overview

CombiGene AB's market cap is currently kr43.76M. The company's EPS TTM is kr0.0606; its P/E ratio is 36.47; and it has a dividend yield of 86.96%. CombiGene AB is scheduled to report earnings on August 21, 2026, and the estimated EPS forecast is kr―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenuekr 0.00kr 326.00Kkr 5.54Mkr 26.70Mkr 84.04M
Gross Profitkr -8.16Mkr -46.78Mkr -21.29Mkr -19.20Mkr 15.16M
Operating Incomekr -12.98Mkr -47.22Mkr -38.60Mkr -6.95Mkr 20.96M
EBITDAkr -7.19Mkr -34.22Mkr -35.98Mkr -5.86Mkr 23.56M
Net Incomekr -12.36Mkr -44.88Mkr -35.66Mkr -6.16Mkr 20.96M
Balance Sheet
Cash & Short-Term Investmentskr 5.84Mkr 73.75Mkr 101.44Mkr 131.78Mkr 136.74M
Total Assetskr 56.73Mkr 75.88Mkr 120.61Mkr 158.22Mkr 166.22M
Total Debtkr 0.00kr 0.00kr 0.00kr 0.00kr 0.00
Net Debtkr -2.59Mkr -73.75Mkr -101.44Mkr -131.78Mkr -136.74M
Total Liabilitieskr 1.24Mkr 4.30Mkr 4.16Mkr 6.10Mkr 7.94M
Stockholders' Equitykr 55.49Mkr 71.58Mkr 116.46Mkr 152.12Mkr 158.28M
Cash Flow
Free Cash Flowkr -12.78Mkr -29.95Mkr -30.67Mkr -16.67Mkr 21.97M
Operating Cash Flowkr -12.78Mkr -29.95Mkr -30.56Mkr -16.67Mkr 22.11M
Investing Cash Flowkr -49.78Mkr -81.00Kkr -988.90Kkr 0.00kr -147.73K
Financing Cash Flowkr -3.96Mkr 0.00kr 0.00kr 0.00kr 65.88M
Currency in SEK

CombiGene AB Earnings and Revenue History

Income Statement >

CombiGene AB Debt to Assets

Balance Sheet >

CombiGene AB Cash Flow

Cash Flow >

CombiGene AB Forecast EPS vs Actual EPS

Earnings >